Fluidda
About Fluidda
Fluidda is a healthcare AI company specializing in Functional Respiratory Imaging (FRI) technology, which integrates high-resolution CT scans, computational fluid dynamics, and artificial intelligence to generate detailed, patient-specific 3D models of lung anatomy and function. This proprietary technology offers physicians unparalleled insights into various aspects of lung health, including airway geometry, lung volumes, airflow patterns, and aerosol deposition characteristics. Unlike conventional lung function tests such as spirometry, FRI provides localized and quantitative information, which is crucial for a more accurate understanding of disease pathophysiology and for guiding personalized treatment strategies.
For healthcare providers, Fluidda’s FRI platform, including its FDA-cleared Broncholab system, facilitates optimized diagnosis, monitoring of disease progression, and assessment of therapeutic efficacy across a spectrum of respiratory conditions. These include asthma, Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), pulmonary hypertension (PH), and sleep-related breathing disorders. The technology is also a vital tool in clinical research, enabling pharmaceutical companies and clinical research organizations (CROs) to accelerate drug and device development by providing highly sensitive biomarkers and optimizing clinical trial design, potentially reducing the number of patients required and overall costs.
Focus Areas
Business Intelligence
| Key Investors | Materialise, Europa, FRI-Invest GmbH, Motion Equity Partners (indirectly via Banook Group acquisition) |
| Partnerships | Banook Group (acquisition), FiGHT campaign, FDA (for biomarker development) |
| Acquisitions | Acquired by Banook Group in November 2025 |
| Technology | Functional Respiratory Imaging (FRI) platform, Broncholab, combines HRCT scans, Computational Fluid Dynamics (CFD), 3D modeling, digital image processing, and Artificial Intelligence (AI) technology, online platform |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Fluidda's Functional Respiratory Imaging (FRI) offers a paradigm shift from conventional lung function tests. Unlike spirometry, which can underestimate disease severity due to compensatory mechanisms in healthy lung areas, FRI provides accurate, regional information on lung function, ventilation, trapped air, airway and nodule volume, and blood flow. This allows for earlier and more precise diagnosis, better monitoring of disease progression, and the ability to select and optimize personalized treatments, especially for patients with limited options or those whose current treatments are failing. The FDA clearance of their Broncholab online platform further enables the integration of these advanced FRI parameters into clinical practice for diagnosis and monitoring of respiratory diseases. FRI can also predict how inhaled drug particles are deposited, aiding in optimizing treatment delivery.
Fluidda's FRI technology is designed to integrate seamlessly with existing hospital infrastructure, utilizing readily available CT and MRI scanners. The Broncholab platform, cleared by the FDA, provides an online interface for physicians to access FRI parameters.
Reviews & Opinions
Videos
News, demos, and interviews about Fluidda.
Videos load interactively. If none appear, search YouTube for Fluidda →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]